Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
      • División de Aviación
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • DEA Museum
    • Divisiones operativas
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Recovery Resources
    • Data and Statistics
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2021 (2)
  • 2019 (2)
  • 2018 (2)

Subject

Drug Name

  • Fentanyl (32)
  • Methamphetamine (29)
  • Heroin (18)
  • Cocaine (14)
  • Synthetic Opioids (12)
  • Marijuana (Cannabis) (6)
  • Ecstasy/MDMA (1)
  • Marijuana Concentrates (1)
  • Opioids (1)
  • Oxycodone (6)
  • Methadone (1)

Field Division

  • Atlanta (46)
  • New York (31)
  • New England (27)
  • Washington, DC (23)
  • Miami (17)
  • Seattle (13)
  • St. Louis (11)
  • Chicago (8)
  • San Francisco (8)
  • Dallas (5)
  • Houston (5)
  • New Jersey (5)
  • Rocky Mountain (4)
  • Sede (3)
  • El Paso (1)
  • San Diego (1)
  • New Orleans (4)
  • Detroit (1)
  • Omaha (1)
Clear All Results

DEA Issues Warning Over Counterfeit Pills

Mayo 21, 2021
NEW ORLEANS – DEA is alerting all citizens to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid fentanyl. Manufactured by Mexican drug trafficking (DTOs), and marketed as a medication such as oxycodone on the illicit drug market, these pills can be deadly. One...

Members of drug ring connecting North Dakota Indian Reservations and Michigan residents face federal charges

Enero 07, 2021
FARGO, N.D., – On January 7, Drew Wrigley, U.S. Attorney for the District of North Dakota, announced charges against 26 defendants involved in Operation Blue Prairie, a drug pipeline connecting individuals in Detroit, Michigan, to the Spirit Lake, Turtle Mountain and Fort Berthold Indian Reservations in North Dakota. Drug Enforcement...

West Bloomfield doctor sentenced to prison for diverting thousands of oxycodone pills

Junio 19, 2019
DETROIT – A Detroit-area doctor was sentenced to 60 months in prison today for his role in a scheme to unlawfully distribute more than 23,000 pills of oxycodone. Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division, U.S. Attorney Matthew Schneider of the Eastern District of Michigan...

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

Mayo 24, 2019
NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...

Montgomery Nurse Practitioner convicted of unlawfully distributing controlled substances, health care fraud, and conspiracy

Octubre 31, 2018
MONTGOMERY, Ala. – On Monday, Oct. 29, 2018, a federal jury convicted nurse practitioner Lilian Ifeoma Akwuba, 39, of Montgomery, Alabama, on 17 counts of unlawfully distributing controlled substances, 4 counts of health care fraud, 1 count of conspiring to distribute controlled substances, and 1 count of conspiring to commit...

New Orleans-area defendants plead guilty to fraudulent possession and black market distribution of oxycodone

Octubre 22, 2018
NEW ORLEANS – Eight New Orleans-area defendants have pleaded guilty for their participation in a conspiracy to obtain oxycodone through fraud by using fictitious prescriptions. Six of the eight defendants have also pleaded guilty for their roles in a scheme to possess with intent to distribute oxycodone on the black...
Showing 1 - 6 of 6 results

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster